Cargando…

Systemic treatment of advanced basal cell carcinoma: how to critically evaluate value for patient and society?

Detalles Bibliográficos
Autores principales:	Hoorens, Isabelle, Van Coile, Laura, Jacobs, Celine, Saerens, Michael, Verhaeghe, Evelien, Brochez, Lieve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751157/ https://www.ncbi.nlm.nih.gov/pubmed/36531830 http://dx.doi.org/10.1177/17588359221141762

Ejemplares similares

Study protocol of the BASINEL Study: a pragmatic randomised controlled trial investigating treatment versus no treatment of low-risk basal cell carcinomas in older persons
por: Van Coile, Laura, et al.
Publicado: (2022)

Lesion‐directed screening to optimize skin cancer detection in dermatology practice: an observational study
por: Mylle, S., et al.
Publicado: (2021)

Can Multispectral Dermoscopy Help In Distinguishing Blue Color?
por: Janssen, Laudine, et al.
Publicado: (2023)

IDO Expression in Cancer: Different Compartment, Different Functionality?
por: Meireson, Annabel, et al.
Publicado: (2020)

Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma
por: Meireson, Annabel, et al.
Publicado: (2021)

Insulin Degludec: A Significant Advancement in Ultralong-Acting Basal Insulin
por: Kalra, Sanjay
Publicado: (2013)

Probability Density Function Models for Float Glass under Mechanical Loading with Varying Parameters
por: Symoens, Evelien, et al.
Publicado: (2023)

Regarding a dermatoscopic pattern for infiltrating basal cell carcinoma
por: Rosendahl, Cliff
Publicado: (2015)

Advances in the management of basal cell carcinoma
por: Lewin, Jesse M., et al.
Publicado: (2015)

How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion
por: Kim, Beom Kyung
Publicado: (2023)

P-cadherin counteracts myosin II-B function: implications in melanoma progression
por: Jacobs, Koen, et al.
Publicado: (2010)

Psoriasis Vulgaris Exacerbation during Treatment with a PD-1 Checkpoint Inhibitor: Case Report and Literature Review
por: De Bock, Marlies, et al.
Publicado: (2018)

Resilience: A Critical Appraisal of the State of Research for Business and Society
por: Buyl, Tine, et al.
Publicado: (2022)

Sonidegib for the Treatment of Advanced Basal Cell Carcinoma
por: Brancaccio, Gabriella, et al.
Publicado: (2020)

Editorial
por: Verhaeghe, J.
Publicado: (2010)

Critical Tips on How to Respond to Peer Reviewers
por: Min, Seung-Kee
Publicado: (2022)

Late Lung Metastasis in a Patient with a Clear Cell Chondrosarcoma: An Indication for a Life-Long Follow-Up?
por: West, Paulien, et al.
Publicado: (2021)

Turning the Tide: How the Women’s Dermatologic Society Leads in Diversifying Dermatology
por: Sekyere, Nana Amma N., et al.
Publicado: (2020)

Value in psoriasis (IRIS) trial: implementing value-based healthcare in psoriasis management – a 1-year prospective clinical study to evaluate feasibility and value creation
por: Hilhorst, Niels, et al.
Publicado: (2023)

Identification of critically carcinogenesis-related genes in basal cell carcinoma
por: Dai, Jie, et al.
Publicado: (2018)

Long non-coding RNAs in cutaneous melanoma: clinical perspectives
por: Hulstaert, Eva, et al.
Publicado: (2017)

Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management?
por: Cagney, Hannah P., et al.
Publicado: (2023)

American Society of Clinical Oncology Reports on Clinical Cancer Advances
por: Viale, Pamela Hallquist
Publicado: (2019)

American Society for Radiation Oncology's Advances in Radiation Oncology in 2022
por: Miller, Robert C., et al.
Publicado: (2022)

“Advances in Preterm Delivery”—How Can We Advance Further?
por: Wainstock, Tamar, et al.
Publicado: (2022)

Does the world need a scientific society for research on how to improve healthcare?
por: Wensing, Michel, et al.
Publicado: (2012)

Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations
por: Mohan, Shalini V., et al.
Publicado: (2014)

Management of high-risk and advanced basal cell carcinoma
por: Puig, S., et al.
Publicado: (2015)

Emerging concepts and recent advances in basal cell carcinoma
por: Totonchy, Mariam, et al.
Publicado: (2017)

Locally Advanced Basal Cell Carcinoma with Intraocular Invasion
por: Tchernev, Georgi, et al.
Publicado: (2018)

Treatment of Locally Advanced Basal Cell Carcinomas with Vismodegib
por: Mastronardi, Luis, et al.
Publicado: (2021)

Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
por: Chen, Olivia M., et al.
Publicado: (2022)

Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia
por: Mesti, Tanja, et al.
Publicado: (2022)

Editorial Comment to Primary basal cell carcinoma of the prostate with concurrent adenocarcinoma
por: Funahashi, Yasuhito
Publicado: (2020)

Value of CD10 Expression in Differentiating Cutaneous Basal from Squamous Cell Carcinomas and Basal Cell Carcinoma from Trichoepithelioma
por: Sari Aslani, Fatemeh, et al.
Publicado: (2013)

Albumin infusion for the critically ill – is it beneficial and, if so, why and how?
por: Das, Undurti N
Publicado: (2015)

How much centralization of critical care services in the era of telemedicine?
por: Ostermann, Marlies, et al.
Publicado: (2019)

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
por: Brochez, Lieve, et al.
Publicado: (2018)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on the Incidence and Thickness of Cutaneous Melanoma in Belgium
por: Demaerel, Philip Georg, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u4t0vjkag01eu0cnufadqcurgn